Using risedronate to prevent bone loss after bariatric surgery
Official title: Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery
Run by Wake Forest University Health Sciences · NCT04922333 · Data updated 2026-11-12
This study is testing if the medication risedronate can help prevent bone and muscle loss in people who have had bariatric surgery.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 30 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | Wake Forest University Health Sciences Academic / other |
| Locations | 1 site (Winston-Salem, North Carolina) |
| Status | Recruiting |
| Started | March 28, 2023 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | February 19, 2026 |
| Trial ID | NCT04922333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are middle-aged and older adults (≥40 years) who have undergone sleeve gastrectomy.
✕Probably not a fit
Patients with a weight greater than 450 lbs or those currently using osteoporosis medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine if the medication risedronate can effectively reduce bone and muscle loss in patients who have undergone bariatric surgery, specifically vertical sleeve gastrectomy. Participants will be randomized to receive either risedronate or a placebo for six months, with assessments of musculoskeletal outcomes at baseline, six months, and twelve months. The study will utilize advanced imaging techniques and biomarkers to evaluate changes in bone density, muscle function, and other relevant health indicators. The trial will involve up to six visits over the course of one year, including monthly follow-ups to monitor participant health and adherence to the medication regimen.
Why it matters
Potential benefit: If successful, this study could provide a new preventive treatment option for patients at risk of bone loss following bariatric surgery.
How similar studies have gone: While bisphosphonates have been effective in treating osteoporosis, this specific application for preventing bone loss after bariatric surgery is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subjects who have had sleeve gastrectomy * Willing to provide informed consent * Agree to all study procedures and assessments. Exclusion Criteria: * Weight greater than 450 lbs * Regular use of growth hormones, oral steroids, or prescription osteoporosis medications; * Known allergies to bisphosphonates * Unstable gastric reflux requiring two or more additional doses per month of anti-reflux medication. * Current participation in other research study * Unable to provide own transportation to study visits * Unable to position on scanner independently.
Where it's running
-
Wake Forest School of Medicine
Winston-Salem, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Kristen Beavers, PhD, MPH, RD — Wake Forest University Health Sciences
- Study coordinator: Kristen Beavers, PhD, MPH, RD
- Email: beaverkm@wfu.edu
- Phone: 336-758-5855
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
All-on-6 upper jaw implants placed with stackable guided surgery and immediate loading
This study will test whether a fully digital stackable guided surgery workflow with immediate loading works well for adults needing full-arch upper jaw (All-on-6) implants.
-
Guided Equator overdentures for the lower jaw
This project tests whether fully guided computer-assisted implant placement with Equator attachments gives reliable implant survival and less bone loss for adults with a completely edentulous lower jaw.
-
How three prosthetic methods affect bone levels around dental implants
This trial will test whether three different prosthetic approaches for posterior dental implants change marginal bone levels around the implant over one year in adults eligible for Lance implants.
-
Mandibular overdentures held by four Locator attachments versus a four-implant bar
This study tests whether mandibular overdentures retained by four Locator attachments or by a four-implant bar better preserve jaw bone in people who have been fully toothless for at least a year.
-
Evaluation of AdvanCore Bone Graft for Bone Healing
This study is testing if the AdvanCore bone graft can help adults with serious bone defects heal better over a year.
-
Comparing high-resolution and pQCT scans to view bone and muscle structure
This study will try high-resolution CT (HR-pQCT), pQCT, and DXA scans to see if they reveal bone and muscle microarchitecture changes in adults at risk of osteoporosis or muscle loss.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.